Publicaciones (17) Publicaciones de Thais Pereira Veiga

2024

  1. Corrigendum to "Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients"

    Molecular & cellular proteomics : MCP

2023

  1. Comparative evaluation of PD-L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non-small cell lung cancer patients

    Molecular Oncology, Vol. 17, Núm. 5, pp. 737-746

  2. The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients

    Cancer Cell International, Vol. 23, Núm. 1

2022

  1. Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma

    Biomedicines, Vol. 10, Núm. 11

  2. Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance

    Cell Reports, Vol. 40, Núm. 9

  3. Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients

    Molecular and Cellular Proteomics, Vol. 21, Núm. 12

2021

  1. Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers

    Clinical and Experimental Metastasis, Vol. 38, Núm. 2, pp. 239-251

2020

  1. Analysis of a real-world cohort of metastatic breast cancer patients shows circulating tumor cell clusters (Ctc-clusters) as predictors of patient outcomes

    Cancers, Vol. 12, Núm. 5

  2. Corrigendum to “Nanoemulsions to support ex vivo cell culture of breast cancer circulating tumor cells” [Materials Today Chemistry 16 (2020) 100265] (Materials Today Chemistry (2020) 16, (S2468519420300252), (10.1016/j.mtchem.2020.100265))

    Materials Today Chemistry

  3. Looking for a better characterization of triple-negative breast cancer by means of circulating tumor cells

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  4. Nanoemulsions to support ex vivo cell culture of breast cancer circulating tumor cells

    Materials Today Chemistry, Vol. 16

  5. Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation

    PLoS ONE, Vol. 15, Núm. 1

2019

  1. CTCs expression profiling for advanced breast cancer monitoring

    Cancers, Vol. 11, Núm. 12

  2. Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients

    Scientific Reports, Vol. 9, Núm. 1

2014

  1. Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b

    Neurobiology of Disease, Vol. 69, pp. 206-214

  2. Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia

    Journal of Psychiatric Research, Vol. 51, Núm. 1, pp. 49-59

2013

  1. Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease

    NeuroMolecular Medicine, Vol. 15, Núm. 2, pp. 295-309